First Trust Advisors’s abrdn Life Sciences Investors HQL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $452K | Buy |
|
|||||
2025
Q1 | $211K | Buy |
|
|||||
2024
Q4 | $175K | Buy |
|
|||||
2024
Q3 | $194K | Buy |
|
|||||
2024
Q2 | $175K | Buy |
|
|||||
2024
Q1 | $142K | Buy |
|
|||||
2023
Q4 | – | Sell |
|
|||||
2023
Q3 | $132K | Buy |
|
|||||
2023
Q1 | – | Sell |
|
|||||
2022
Q4 | $242K | Hold |
|
|||||
2022
Q3 | $233K | Sell |
|
|||||
2022
Q2 | $261K | Sell |
|
|||||
2022
Q1 | $315K | Sell |
|
|||||
2021
Q4 | $404K | Buy |
|
|||||
2021
Q3 | $422K | Buy |
|
|||||
2021
Q2 | $406K | Buy |
|
|||||
2021
Q1 | $360K | Sell |
|
|||||
2020
Q4 | $401K | Sell |
|
|||||
2020
Q3 | $381K | Sell |
|
|||||
2020
Q2 | $413K | Hold |
|
|||||
2020
Q1 | $345K | Sell |
|
|||||
2019
Q4 | $448K | Buy |
|
|||||
2019
Q3 | $347K | Buy |
|
|||||
2019
Q2 | $328K | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $952K | Buy |
|
|||||
2016
Q3 | $954K | Sell |
|
|||||
2016
Q2 | $993K | Sell |
|
|||||
2016
Q1 | $1.54M | Buy |
|
|||||
2015
Q4 | $2M | Sell |
|
|||||
2015
Q3 | $1.96M | Buy |
|
|||||
2015
Q2 | $2M | Buy |
|
|||||
2015
Q1 | $1.47M | Sell |
|
|||||
2014
Q4 | $1.59M | Buy |
|
|||||
2014
Q3 | $1.33M | Buy |
|
|||||
2014
Q2 | – | Sell |
|
|||||
2014
Q1 | $1.12M | Sell |
|
|||||
2013
Q4 | $1.15M | Buy |
|
|||||
2013
Q3 | $919K | Buy |
|
|||||
2013
Q2 | $785K | Buy |
|